Strs Ohio Clovis Oncology, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 06, 2018	SELL	$42.06 - $62.4 $105,150 - $156,000	-2,500 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$50.12 - $67.72 $30,072 - $40,632	-600 Reduced 19.35%	2,500 $132,000
Q4 2017 Jan 23, 2018	SELL	$57.69 - $84.58 $121,149 - $177,618	-2,100 Reduced 40.38%	3,100 $210,000
Q3 2017 Oct 23, 2017	BUY	$67.17 - $84.81 $349,284 - $441,012	5,200	5,200 $428,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.